Cessatech AS (XSAT:CESSA) OCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CESSA Cessatech AS XSAT:CESSA
28 GF Score
Price kr10.40
! 2 Warning Signs
View Full Analysis

What is Cessatech AS OCF Margin %?

Cessatech AS XSAT:CESSA +3.48% 28 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates XSAT:CESSA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 953 Biotechnology companies, Cessatech AS ranks worse than 62.85% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cessatech AS's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-3.28 Mil. Cessatech AS's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Cessatech AS's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Cessatech AS's current OCF Yield % is -9.16%.

The historical rank and industry rank for Cessatech AS's OCF Margin % or its related term are showing as below:

XSAT:CESSA' s OCF Margin % Range Over the Past 10 Years
Min: -307.47   Med: -298.69   Max: -289.9
Current: -216.65

During the past 6 years, the highest OCF Margin % of Cessatech AS was -289.90%. The lowest was -307.47%. And the median was -298.69%.

XSAT:CESSA's OCF Margin % is ranked worse than
62.85% of 953 companies
in the Biotechnology industry
Industry Median: -64.23 vs XSAT:CESSA: -216.65

Cessatech AS OCF Margin % Related Terms

Cessatech AS OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cessatech AS's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cessatech AS OCF Margin % Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 -289.90 -307.47

Cessatech AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 464.60 446.10 479.57 -3.18 0.00

XSAT:CESSA vs VRTX, REGN, RVMD: OCF Margin % Comparison

For the Biotechnology subindustry, Cessatech AS's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cessatech AS OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Cessatech AS's OCF Margin % falls into.


XSAT:CESSA
28GF Score
Cessatech AS XSAT:CESSA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cessatech AS OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cessatech AS's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-17.581/5.718
=-307.47 %

Cessatech AS's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.275/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Cessatech AS (XSAT:CESSA) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cessatech AS and its competitors. According to the industry distribution chart, Cessatech AS ranks #599 out of 953 companies in the Biotechnology industry, placing it in the top 62.9%.
Is Cessatech AS's OCF Margin % too high?
Cessatech AS's current OCF Margin % is 0.00%. Based on the distribution chart, Cessatech AS ranks #599 out of 953 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Cessatech AS has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Cessatech AS's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cessatech AS ranks #599 out of 953 companies for OCF Margin %. This places Cessatech AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cessatech AS and its competitors. Cessatech AS's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cessatech AS stock overvalued right now?
Cessatech AS (XSAT:CESSA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Cessatech AS's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cessatech AS (XSAT:CESSA), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cessatech AS Business Description

Other Exchanges 8GN:Germany
Address Strandvejen 60, Hellerup, DNK, DK- 2900
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. The company is advancing a pipeline comprising three assets, all addressing an unmet medical need in the treatment of children. The main candidate, CT001, a fixed-dose nasal spray for treating acute pain in children, is in the pre-launch phase in the U.S. and the EU. CT002, a non-invasive intranasal sedation for children undergoing medical procedures (e.g., MRI scans), has an approved PIP in the EU. CT003, a topical anaesthetic, is currently in pre-clinical development.
28GF Score

Get the complete analysis for XSAT:CESSA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.40
Price